# ðŸ“ˆ DAILY TRADING PLAN - September 30, 2025
## ChatGPT TradingAgents Analysis

---

# ðŸš€ SHORGAN-BOT Daily Trading Plan (Catalyst Offense)

## Strategy: Event-driven catalysts, FDA binary events, momentum plays

| Ticker   | Direction | Catalyst (Date/Type)             | Entry   | Stop    | Target  | Sizing | Notes |
| -------- | --------- | -------------------------------- | ------- | ------- | ------- | ------ | ----- |
| **ARQT** | Long      | FDA sNDA (Oct 13, eczema)        | $17.50  | $15.00  | $22.00  | ~15%   | Risk ~1% per stop |
| **GKOS** | Long      | FDA Approval (Oct 20, Epioxa)    | $80.00  | $72.00  | $100.00 | ~15%   | Binary catalyst |
| **SNDX** | Long      | FDA sNDA (Oct 25, Revuforj AML)  | $15.50  | $13.50  | $20.00  | ~15%   | FDA event |
| **CRS**  | Long      | Aerospace momentum + A&D reclass | $251.00 | $230.00 | $280.00 | ~20%   | Use trailing stops |
| **TLRY** | Short     | Cannabis rally unwind            | $1.80   | $2.20   | $1.20   | ~10%   | Speculative - small size |

### SHORGAN-BOT Key Points:
- **Total Allocation**: ~70% across 5 positions
- **Risk Management**: ~1% risk per stop
- **Catalyst Focus**: 3 FDA events (Oct 13, 20, 25)
- **Momentum Play**: CRS aerospace theme
- **Short Position**: TLRY cannabis unwind (speculative)

---

# ðŸ›¡ï¸ DEE-BOT Daily Trading Plan (Defensive Beta-Neutral)

## Strategy: S&P 100 defensive, beta â‰ˆ 1.0, dividend quality

| Ticker   | Direction | Catalyst / Role           | Entry   | Stop    | Target  | Sizing        | Notes |
| -------- | --------- | ------------------------- | ------- | ------- | ------- | ------------- | ----- |
| **PG**   | Long      | Consumer staples ballast  | $166.00 | $155.00 | $178.00 | ~15%          | Defensive core |
| **JNJ**  | Hold      | Defensive pharma core     | $154.00 | $146.00 | $170.00 | ~15%          | Quality dividend |
| **PEP**  | Long      | Staple/cyclical balance   | $169.00 | $160.00 | $180.00 | ~15%          | Consumer staple |
| **ABBV** | Long      | Healthcare yield + growth | $156.00 | $147.00 | $170.00 | ~15%          | Pharma quality |
| **SPY**  | Trim      | Beta hedge post-rally     | $668.00 | $630.00 | $690.00 | Adjust sizing | Maintain beta 1.0 |

### DEE-BOT Key Points:
- **Beta Target**: â‰ˆ 1.0 (maintain with SPY hedge)
- **Cash Reserve**: ~3%
- **Rebalance Trigger**: If beta drifts >0.15
- **Focus**: Defensive quality, dividend stability

---

# ðŸ“Š COMBINED DASHBOARD VIEW

## Today's Market Setup
- **Market**: SPY at $668 (near highs)
- **Volatility**: VIX low (defensive opportunity)
- **Catalysts**: Multiple FDA dates Oct 13-25
- **Macro**: Consumer staples strong, cannabis weak

## Portfolio Allocation Summary

| Bot | Strategy | Positions | Cash | Beta | Risk Level |
|-----|----------|-----------|------|------|------------|
| SHORGAN | Catalyst | 5 (4 long, 1 short) | ~30% | N/A | High |
| DEE | Defensive | 5 (4 long, 1 trim) | ~3% | 1.0 | Low |

## Key Catalysts Calendar

| Date | Event | Ticker | Type | Priority |
|------|-------|--------|------|----------|
| Oct 13 | FDA sNDA | ARQT | Eczema approval | HIGH |
| Oct 20 | FDA Approval | GKOS | Epioxa drug | HIGH |
| Oct 25 | FDA sNDA | SNDX | AML treatment | HIGH |
| Ongoing | Aerospace momentum | CRS | Sector strength | MEDIUM |
| Ongoing | Cannabis unwind | TLRY | Short thesis | LOW |

---

# ðŸŽ¯ EXECUTION PLAN

## Pre-Market Checklist (Before 9:30 AM)
- [ ] Verify account cash availability
- [ ] Check pre-market prices for all tickers
- [ ] Review FDA calendar for any updates
- [ ] Confirm stop-loss levels
- [ ] Check overall portfolio beta (DEE)

## Market Open (9:30 AM)

### Priority 1 - DEE-BOT Entries
1. **BUY PG** ~15% of portfolio @ $166.00 LIMIT
2. **BUY PEP** ~15% of portfolio @ $169.00 LIMIT
3. **BUY ABBV** ~15% of portfolio @ $156.00 LIMIT
4. **TRIM SPY** - Adjust to maintain beta 1.0

### Priority 2 - SHORGAN-BOT Entries
1. **BUY ARQT** ~15% of portfolio @ $17.50 LIMIT
2. **BUY GKOS** ~15% of portfolio @ $80.00 LIMIT
3. **BUY SNDX** ~15% of portfolio @ $15.50 LIMIT
4. **BUY CRS** ~20% of portfolio @ $251.00 LIMIT
5. **SHORT TLRY** ~10% of portfolio @ $1.80 LIMIT (if long-only: SKIP)

### Priority 3 - Stop Loss Orders
- Set stop-loss orders immediately after fills
- Use STOP LIMIT orders (not STOP MARKET)
- Verify all stops are active

## Midday Review (12:00 PM)
- Check if all orders filled
- Adjust any unfilled limit orders
- Monitor FDA news flow
- Verify portfolio beta (DEE)

## Market Close (4:00 PM)
- Final position check
- Verify all stop-losses active
- Update position tracking
- Review performance vs plan

---

# âš ï¸ RISK MANAGEMENT

## SHORGAN-BOT Risks
- **Binary FDA events**: 3 positions with approval risk
- **Short position**: TLRY could squeeze (small size)
- **CRS momentum**: Could reverse quickly (use trailing stops)
- **Overall**: High risk/reward profile appropriate for strategy

## DEE-BOT Risks
- **Beta drift**: Monitor and rebalance if >0.15 from target
- **Market pullback**: Defensive positions should cushion
- **Dividend cuts**: Unlikely with PG/JNJ/PEP/ABBV quality
- **Overall**: Low risk, stable profile

## Portfolio-Level Risks
- **Concentration**: Each position sized appropriately
- **Correlation**: DEE positions negatively correlated with SHORGAN
- **Liquidity**: All tickers liquid (>1M ADV)
- **Cash**: Adequate reserves in both accounts

---

# ðŸ“‹ POSITION SIZING CALCULATIONS

## SHORGAN-BOT ($100K Portfolio)
- **ARQT**: 15% = $15,000 / $17.50 = ~857 shares
- **GKOS**: 15% = $15,000 / $80.00 = ~187 shares
- **SNDX**: 15% = $15,000 / $15.50 = ~967 shares
- **CRS**: 20% = $20,000 / $251.00 = ~79 shares
- **TLRY**: 10% = $10,000 / $1.80 = ~5,555 shares (SHORT)
- **Cash**: 25% = $25,000 reserve

## DEE-BOT ($100K Portfolio)
- **PG**: 15% = $15,000 / $166.00 = ~90 shares
- **JNJ**: 15% = Hold existing position
- **PEP**: 15% = $15,000 / $169.00 = ~88 shares
- **ABBV**: 15% = $15,000 / $156.00 = ~96 shares
- **SPY**: Trim to maintain beta 1.0
- **Cash**: 3% = $3,000 reserve

---

# ðŸŽ¯ SUCCESS METRICS

## Today's Goals
- [ ] All DEE-BOT entries filled at or near target prices
- [ ] All SHORGAN-BOT entries filled at or near target prices
- [ ] Stop-loss orders active for all positions
- [ ] DEE-BOT beta maintained at 0.85-1.15
- [ ] No capital deployed >80% (maintain cash reserve)

## This Week's Goals
- Monitor FDA calendar events
- Protect CRS gains with trailing stops
- Rebalance DEE-BOT if beta drifts
- Review TLRY short thesis daily

---

# ðŸ“ž NOTES & REMINDERS

## Critical Dates:
- **Oct 13**: ARQT FDA decision
- **Oct 20**: GKOS FDA decision
- **Oct 25**: SNDX FDA decision

## Daily Monitoring:
- CRS aerospace momentum
- TLRY cannabis sector weakness
- DEE-BOT beta calculation
- Overall portfolio correlation

## Strategy Alignment:
âœ… SHORGAN-BOT: Catalyst-heavy, binary events, momentum
âœ… DEE-BOT: Defensive, beta-neutral, quality dividends
âœ… Both bots aligned with TradingAgents framework

---

**Generated from ChatGPT TradingAgents Deep Research**
**Execute with proper risk management and position sizing**
**All trades subject to market conditions and liquidity**